Cytokine-Based Cancer Immunotherapies Summit Boston | Hyatt Regency Boston, MA
Evvnt Promotion / evvnt
Archive
30.11.2021 - 02.12.2021 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 8:20 am - 5:00 pm
Conference themes
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.
Welcome to the only in person dedicated industry forum supporting the development of robust cytokine-based cancer immunotherapy platforms (cytokine muteins, antibody-cytokine fusion proteins (immunokines), anticancer vaccines, and cancer-directed antibodies) to deliver targeted, durable therapeutic interventions to solid tumor and hematological cancer indications.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Brochure: https://go.evvnt.com/850076-3?pid=4832
Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more
Brochure: https://go.evvnt.com/850076-3?pid=4832
Speakers: Dario Neri, Co-CEO and CSO, Professor, Philogen and ETH Zurich, Khursheed Anwer, Chief Scientific Officer and Executive Vice President, Celsion and more
Enquiries and Registration:
https://go.evvnt.com/850076-1?pid=4832
Ms. Emily Birt
General Medicine, Oncology
Languages
English
English
Congress fees
USD 2599.00 - USD 4797.00
USD 2599.00 - USD 4797.00
Participants expected
1000
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
